Ezio Ghigo

Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Part of Ipsen SA, Ipsen NV is a Belgian biopharmaceutical company that improves patients' lives through research and innovation in oncology, rare disease, and neuroscience. Founded in 1982, the company is based in Merelbeke, Belgium. Ipsen is a global mid-sized biopharmaceutical company that focuses on improving patients' lives through its research and innovation in the field of oncology, rare diseases, and neuroscience.

UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.

Europeptides GEIE is a French pharmaceutical company that specializes in researching and developing products for the reproductive health care sector. The company is based in Argenteuil, France. Europeptides GEIE was acquired by Ardana Plc from E.ON SE on July 11, 2002 for $27.87 million.